{Reference Type}: Journal Article
{Title}: Radiotherapy as Part of Treatment Strategies in Nasal Cavity and Paranasal Sinus Malignancies.
{Author}: Owin N;Elsayad K;Rolf D;Haverkamp U;Suwelack D;Tschakert R;Berssenbrugge H;Kleinheinz J;Rudack C;Eich HT;
{Journal}: Anticancer Res
{Volume}: 41
{Issue}: 3
{Year}: Mar 2021
{Factor}: 2.435
{DOI}: 10.21873/anticanres.14919
{Abstract}: <B>OBJECTIVE: </B>Modern intensity-modulated radiotherapy (IMRT) is frequently applied to treat patients with nasal cavity and paranasal sinus (NC/PNS) malignancies.<BR><B>METHODS: </B>One hundred and four patients who underwent radiotherapy (RT) between 1994 and 2020 were recognized. This analysis compared conventional-radiotherapy (CRT) and image-guided IMRT outcomes for NC/PNS malignancies.<BR><B>RESULTS: </B>The median follow-up was 69 months. Eighty-eight patients (85%) were managed with image-guided IMRT. The median initial radiation dose was 65 Gy, with 68 Gy applied for patients treated with primary RT versus 63 Gy applied for adjuvant therapy (p=0.1). The 5-year locoregional control (LRC) was 85%. The locoregional recurrence rate was 18% following IMRT versus 31% in the 2D/3D-conventional RT group (p=0.09). Moreover, IMRT was associated with a lower inner-ear toxicity rate (8% vs. 20%, respectively; p=0.045).<BR><B>CONCLUSIONS: </B>IMRT appears to be linked with higher LRC and lower inner-ear acute toxicities compared to conventional RT.